{"lastClose": 7.380000114440918, "len": 582, "date": "2023-03-31", "alpha_1": 1.594056485290583, "beta_1": 1.1269917935929679, "drawup_1": 2.551601332904123, "sharpe_1": 0.9562362299059537, "natr_1": 6.39247147246065, "sup_1": -0.01716353140855666, "res_1": 0.41011740316469114, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 39.70190320001582, "adx_1": 26.56357633729436, "drawdown_1": -0.4311741072406756, "stratHoldSharpe_1": 0.8787565972966397, "stratHoldAlpha_1": 251.59989817351044, "stratHoldDrawdown_1": -0.388056696516608, "alpha_3mo": -0.5770238843895992, "beta_3mo": 0.4884007683198195, "drawup_3mo": 0.22604411809674274, "natr_3mo": 6.39247147246065, "sup_3mo": -0.05880758923154398, "res_3mo": 0.06070459990197055, "bullPattern_3mo": ["HARAMI"], "bearPattern_3mo": [], "rsi_3mo": 44.47174769577559, "adx_3mo": 14.872973759427902, "drawdown_3mo": -0.30661318700388385, "stratHoldSharpe_3mo": -0.3256762619846048, "stratHoldAlpha_3mo": 250.80416973359823, "stratHoldDrawdown_3mo": -0.2811351189791993, "Country": "United Kingdom", "Industry": "Biotechnology: Pharmaceutical Preparations", "Sector": "Health Care", "Market Cap": 5597193843, "Name": "Roivant Sciences Ltd.", "alpha%_1": 0.9999999039822972, "beta%_1": 0.6205204059602943, "drawup%_1": 0.9999999942366135, "sharpe%_1": 0.7723467236987205, "natr%_1": 0.839376010742757, "drawdown%_1": 0.3987417065657157, "stratHoldSharpe%_1": 0.8816861699219687, "stratHoldAlpha%_1": 0.988038850959368, "stratHoldDrawdown%_1": 0.40768594627054006, "alpha%_3mo": 0.21998519686339113, "beta%_3mo": 0.17428973856028013, "drawup%_3mo": 0.5541357206558788, "natr%_3mo": 0.8303559129694089, "drawdown%_3mo": 0.16511426034476528, "stratHoldSharpe%_3mo": 0.29846386715023066, "stratHoldAlpha%_3mo": 0.27044892319556124, "stratHoldDrawdown%_3mo": 0.1635275404861916}